In the ever-evolving landscape of technological innovation, a new wave of AI computers is poised to revolutionize computation as we know it. With processors designed specifically for AI programs, these machines unlock a realm of possibilities for individuals, governments, and scientific organizations alike. At the forefront of this transformative wave is Danish...
Fundamentals: An insulin and diabetes drug care company based in Denmark. Booming fundamentals, booming funds, great cashflow, stable earnings and accelerating sales. Pays a little dividend. Technicals: Shallow pb uHd extreme indicator 34%-50% pb a-b-c pb completion horizonal support kijun bounce strong volume today at support Outlook: Expected to hold for 8...
Here's another video highlighting the trades I took this morning and yesterday and some of the longer term swing positions I'm in with analysis as to why I took them. Hope this was helpful Happy Trading :)
Novo Nordisk's CEO, Lars Fruergaard Jørgensen, has announced that the company's experimental weight loss pill, "Amycretin," could become a leading medication in its class. In an early-stage study, participants lost an average of 13% of their body weight after 12 weeks. By comparison, patients using the injectable diabetes weight loss medications Ozempic and...
Novo Nordisk ( NYSE:NVO ) made waves in the pharmaceutical industry as its stock skyrocketed to unprecedented heights following the announcement of groundbreaking results from its experimental oral weight-loss drug, amycretin. The drugmaker's innovative approach, which combines GLP-1 and amylin hormones, surpassed expectations by demonstrating remarkable efficacy...
I think Novo Nordisk is moving inside a consolidation channel preparing a strong upside move to reach a new ATH There will be an enormous demand for obesity drugs in the next years
Over a billion people worldwide suffer from obesity. Physical exercise and various treatments often require a lot of effort and time to have any noticeable result. If a pharmaceutical company comes along and invents a magical drug that can help people lose weight without making any effort, that would undoubtedly revolutionize the industry. This is essentially...
The Big 4 Earnings Releases today (POSITIVE) ✅ Novo Nordisk ⬆️ ✅ Mastercard ⬆️ ⌛️ Qualcomm (released later today) ✅ Boston Scientific ⬆️ The chart shows expected & reported earnings & price action. IMO Mastercard looks particularly promising. NYSE:NVO NYSE:MA NASDAQ:QCOM NYSE:BSX
In the first video analysis published in November NYSE:NVO we gave a first explanation of why we were expecting a prosecution of the rally. In this video, you will find some other valuable information on what to expect for current month and also beginning of February. Enjoy!
Novo failed yesterday to achieve a new all time high and dropped Now bouncing on support 96,5 I think will going to break upside reasistance soon
NYSE:NVO bearish,it lokks bearish to me and to other my felow traders , expecting it to fall to98$ at the end of next week
Novo Nordisk is emerging from a textbook volatility compression pattern (VCP) - the setup made famous by Mark Minervini. Notice the series of progressively shallower pullbacks from left to right as supply has been absorbed by buyers. NVO is a market-leading stock by all accounts. Shares are up 75% over the last twelve months with no signs of slowing down. This is...
it addresses on major conditions of humans Diabetes Cardio Alzheimer's from acquisition to partnering and continuous r&d this issue is a model to new science and tech companies making it to the next 50 years key is innovation opportunity is wait for major crash to upsize for OG investors or simply appreciate the Business and Leadership behind the company....
Through the application of the Wave analysis (Hurst, Gann, Swing trading etc) investors can be aware what to expect over the short and mid term. From 16.11 be aware that a retracement might happened. Intensity has to be monitored to understand the type of wave in development (Ti, T+2i or T+3i).
NVO seemingly cannot be stopped and continues the uptrend, I tried to show this in a variety of wars. I added a local demand for another supportive region. The teal support is from september 2022, we are either going to dip into demand and consolidate nearby or jump to 106 in the coming week or two.
NVO is consolidating above the dashed green line which is good news for the bulls. New all time highs are on the horizon. Many have a hard time buying into 52 week highs, but the best compounders spend a lot of their time in this range, that is the nature of successful stocks and companies. I added a local demand that is the green box as a supportive region.
NVO looks like it may breakdown here if this dotted red line of support is broken. RSI is very low but can certainly be lower. Tech stocks are rebounding which may put NVO and others out of favor for a few weeks.
NVO carries my best trade of the year on the last bull-flag setup. This stock appears to be unstoppable even at over a 400 billion dollar market cap.